Search Results - S. Intidhar Labidi-Galy
- Showing 1 - 10 results of 10
-
1
-
2
-
3
Durable complete response with chemo-immuno-radiotherapy for metastatic cervical cancer progressing under immunotherapy: a case series by Thomas Westerhoff, Nathalie Baudoux, Manuela Undurraga, Patrick Petignat, Intidhar Labidi-Galy, Melpomeni Kountouri
Published in Gynecologic Oncology Reports (2025-10-01)Get full text
Article -
4
-
5
Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervix by Marie-Gabrielle Courtès, Melpomeni Kountouri, Wenwen Wang, Jean-Christophe Tille, Patrick Petignat, Manuela Undurraga, S.Intidhar Labidi-Galy
Published in Gynecologic Oncology Reports (2024-06-01)Get full text
Article -
6
Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (Ch... by Delphine S Courvoisier, Christian Toso, Frederic Ris, Dina Zekry, Nadia Elia, Bernhard Walder, Julien Maillard, Stefan Mönig, Intidhar Labidi Galy, Isabelle Zaccaria
Published in BMJ Open (2023-02-01)Get full text
Article -
7
Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of ad... by Patrick Petignat, Manuela Undurraga, Christian Toso, Frederic Ris, Martin Hübner, Noemie Lang, Antonella Diciola, Intidhar Labidi-Galy, Mariagrazia Di Marco, Nicolas Mach
Published in BMJ Open (2023-01-01)Get full text
Article -
8
Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study by Noémie Lang, Aurélie Ayme, Chang Ming, Jean‑Damien Combes, Victor N. Chappuis, Alex Friedlaender, Aurélie Vuilleumier, José L. Sandoval, Valeria Viassolo, Pierre O. Chappuis, S. Intidhar Labidi-Galy
Published in Swiss Medical Weekly (2023-03-01)Get full text
Article -
9
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours by Diego Dibitetto, Martin Liptay, Francesca Vivalda, Hülya Dogan, Ewa Gogola, Martín González Fernández, Alexandra Duarte, Jonas A. Schmid, Morgane Decollogny, Paola Francica, Sara Przetocka, Stephen T. Durant, Josep V. Forment, Ismar Klebic, Myriam Siffert, Roebi de Bruijn, Arne N. Kousholt, Nicole A. Marti, Martina Dettwiler, Claus S. Sørensen, Jean-Christophe Tille, Manuela Undurraga, Intidhar Labidi-Galy, Massimo Lopes, Alessandro A. Sartori, Jos Jonkers, Sven Rottenberg
Published in Nature Communications (2024-05-01)Get full text
Article -
10
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma by Olivia Le Saux, Maude Ardin, Justine Berthet, Sarah Barrin, Morgane Bourhis, Justine Cinier, Yasmine Lounici, Isabelle Treilleux, Pierre-Alexandre Just, Guillaume Bataillon, Aude-Marie Savoye, Marie-Ange Mouret-Reynier, Elodie Coquan, Olfa Derbel, Louis Jeay, Suliman Bouizaguen, Intidhar Labidi-Galy, Séverine Tabone-Eglinger, Anthony Ferrari, Emilie Thomas, Christine Ménétrier-Caux, Eric Tartour, Isabelle Galy-Fauroux, Marc-Henri Stern, Magali Terme, Christophe Caux, Bertrand Dubois, Isabelle Ray-Coquard
Published in Nature Communications (2024-07-01)Get full text
Article
